Compare Organon & Co. Common Stock (OGN) vs Wix.Com Ltd (WIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Organon & Co. Common Stock vs Wix.Com Ltd — how do they compare? Organon & Co. Common Stock trades at $13.58 (market cap $3.62B), while Wix.Com Ltd trades at $74.09 (market cap $3.00B). The key difference: Organon & Co. Common Stock is the larger of the two by market cap, and Organon & Co. Common Stock pays a 0.58% dividend while Wix.Com Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Organon & Co. Common Stock for 0 Days and Wix.Com Ltd for 62 Days on average.
| OGN | WIX | |
|---|---|---|
Market Cap | $3.62B | $3.00B |
Volume | 2,892,999 | 960,938 |
Sector | Health | Technology |
52-Week High | $13.81 | $145.54 |
52-Week Low | $5.70 | $40.43 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $11.04B | $4.08B |
Dividend Yield | 0.58% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Organon (OGN) trades at $13.77, showing no change in the latest session. The stock demonstrates strong profitability with 52.68% gross margins and 24.04% ROE, though recent quarterly earnings have missed expectations. Valuation appears reasonable with P/E of 17.65 and P/S of 0.59. The company shows positive cash flow trends with 2026 projections indicating $533M net cash flow. Recent FDA developments for MIUDELLA and VTAMA products highlight ongoing pipeline progress.
OGN presents a mixed outlook with solid fundamentals offset by earnings misses. The healthcare company's improving cash flow and product pipeline offer potential upside, but investor sentiment remains divided with analysts showing cautious optimism. Key risks include execution challenges and competitive pressures in the pharmaceutical sector.
WIX trades at $74.31, up 0.18% on the day, with a bearish technical signal from moving averages but neutral oscillators. Revenue growth is strong, reaching $1.99B in 2025, though net income margin turned negative at -8.19% in 2026. The company faces multiple class-action lawsuits filed in September 2026, adding legal overhangs. Analyst consensus remains bullish with a $77.00 price target, but negative equity and volatile cash flows highlight financial instability.
The outlook is mixed: robust revenue growth and analyst support offer upside, but profitability challenges, negative equity, and legal risks pose significant headwinds. Investors should weigh the high P/E of 62.84 against earnings volatility and litigation uncertainties before considering a position.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Organon & Co. Common Stock
Organon & Co. is a global healthcare company focused on women's health, biosimilars, and established brands, spun off from Merck & Co. in 2021. Its portfolio of more than 70 medicines includes contraception and fertility therapies, immunology and oncology biosimilars, and treatments in cardiovascular, respiratory, and dermatology, distributed in over 140 countries.
Read more on OGN →About Wix.Com Ltd
Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →
